The same lentiviral ORC6-expressing construct was employed to generate ORC6-overexpressing cells (“oeORC6”) in additional patient-derived primary human glioma cells (“P2/P3”) and immortalized A172 cells. This evidence concerns the gene ORC6 and central nervous system cancer.